Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.00 GBP
−3.93 M GBP
0.00 GBP
425.26 M
About POOLBEG PHARMA PLC ORD GBP0.0002
Sector
CEO
Jeremy Skillington
Headquarters
London
Website
Founded
2021
ISIN
GB00BKPG7Z60
FIGI
BBG011J1D8K9
Poolbeg Pharma Plc is a clinical-stage infectious disease pharmaceutical company. The firm's capital light clinical model enables to develop multiple products faster than the traditional biotech model. Its portfolio includes POLB 001, Phase II ready, repositioned small molecule immunomodulatory for severe influenza, along with a vaccine discovery platform, PredictViral biomarker platform, and the disease progression data & bio banks that will be interrogated using AI platforms. The company was founded on March 19, 2021 and is headquartered in London, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of POLB is 7.60 GBX — it has increased by 0.13% in the past 24 hours. Watch POOLBEG PHARMA PLC ORD GBP0.0002 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange POOLBEG PHARMA PLC ORD GBP0.0002 stocks are traded under the ticker POLB.
POLB stock has fallen by −6.34% compared to the previous week, the month change is a −6.22% fall, over the last year POOLBEG PHARMA PLC ORD GBP0.0002 has showed a −19.71% decrease.
We've gathered analysts' opinions on POOLBEG PHARMA PLC ORD GBP0.0002 future price: according to them, POLB price has a max estimate of 19.00 GBX and a min estimate of 19.00 GBX. Watch POLB chart and read a more detailed POOLBEG PHARMA PLC ORD GBP0.0002 stock forecast: see what analysts think of POOLBEG PHARMA PLC ORD GBP0.0002 and suggest that you do with its stocks.
POLB reached its all-time high on May 7, 2024 with the price of 15.76 GBX, and its all-time low was 4.00 GBX and was reached on Aug 16, 2022. View more price dynamics on POLB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
POLB stock is 2.63% volatile and has beta coefficient of 1.35. Track POOLBEG PHARMA PLC ORD GBP0.0002 stock price on the chart and check out the list of the most volatile stocks — is POOLBEG PHARMA PLC ORD GBP0.0002 there?
Yes, you can track POOLBEG PHARMA PLC ORD GBP0.0002 financials in yearly and quarterly reports right on TradingView.
POOLBEG PHARMA PLC ORD GBP0.0002 is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
POLB net income for the last half-year is −2.26 M GBP, while the previous report showed −2.12 M GBP of net income which accounts for −6.51% change. Track more POOLBEG PHARMA PLC ORD GBP0.0002 financial stats to get the full picture.
No, POLB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, POLB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade POOLBEG PHARMA PLC ORD GBP0.0002 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So POOLBEG PHARMA PLC ORD GBP0.0002 technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating POOLBEG PHARMA PLC ORD GBP0.0002 stock shows the sell signal. See more of POOLBEG PHARMA PLC ORD GBP0.0002 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.